UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Retraction Note: Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor

Oncogene, 2023-02, Vol.42 (8), p.626-626

2023

Volltextzugriff (PDF)

Prospective Iterative Trial of Proteasome Inhibitor‐Based Desensitization

American journal of transplantation, 2015-01, Vol.15 (1), p.101-118

2015

Volltextzugriff (PDF)

Correction: Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma

Oncogene, 2024-10, Vol.43 (41), p.3078-3078

2024

Volltextzugriff (PDF)

Correction: Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and β-arrestin1

Oncogene, 2023, Vol.42 (3), p.253-253

2023

Volltextzugriff (PDF)

Role of insulin-like growth factor I receptor signalling in cancer

British journal of cancer, 2005-06, Vol.92 (12), p.2097-2101

2005

Volltextzugriff (PDF)

Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor

Oncogene, 2012-01, Vol.31 (3), p.352-365

2012

Volltextzugriff (PDF)

β-arrestin1 is involved in the Ras-induced malignant transformation

ANNALS OF ONCOLOGY, 2019, Vol.30, p.v812-v813

2019

Volltextzugriff (PDF)

2035P - β-arrestin1 is involved in the Ras-induced malignant transformation

Annals of oncology, 2019-10, Vol.30 (Supplement_5), p.v812-v813

2019

Volltextzugriff (PDF)

Randomized Controlled Pilot Study of B Cell–Targeted Induction Therapy in HLA Sensitized Kidney Transplant Recipients

American journal of transplantation, 2013-12, Vol.13 (12), p.3142-3154

2013

Volltextzugriff (PDF)

Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma

Oncogene, 2017-06, Vol.36 (23), p.3274-3286

2017

Volltextzugriff (PDF)

Functional antagonism of β-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes

Oncogene, 2017-10, Vol.36 (41), p.5734-5744

2017

Volltextzugriff (PDF)

Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma

Neuro-oncology (Charlottesville, Va.), 2010-01, Vol.12 (1), p.19-27

2010

Volltextzugriff (PDF)

Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real‐world setting

Journal of the European Academy of Dermatology and Venereology, 2021-01, Vol.35 (1), p.105-115

2021

Volltextzugriff (PDF)

Chapter Seven - When Phosphorylation Encounters Ubiquitination: A Balanced Perspective on IGF-1R Signaling

Progress in molecular biology and translational science, 2016, Vol.141, p.277

2016

Volltextzugriff (PDF)

Corrigendum: Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real‐world setting

Journal of the European Academy of Dermatology and Venereology, 2021-06, Vol.35 (6), p.1407-1407

2021

Volltextzugriff (PDF)

Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and β-arrestin1

Oncogene, 2008-03, Vol.27 (11), p.1629-1638

2008

Volltextzugriff (PDF)

Prevalence and determinants of sunbed use in thirty European countries: data from the Euromelanoma skin cancer prevention campaign

Journal of the European Academy of Dermatology and Venereology, 2019-03, Vol.33 (S2), p.13-27

2019

Volltextzugriff (PDF)

Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation

Cellular and molecular life sciences : CMLS, 2014-07, Vol.71 (13), p.2403-2427

2014

Volltextzugriff (PDF)

Correlation between Solid Phase Assays and Positive CDC Crossmatches in a Surrogate Transplant Model

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S398-S398

2016

Volltextzugriff (PDF)

RETRACTED ARTICLE:Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor

Oncogene, 2012-01, Vol.31 (3), p.352-365

2012

Volltextzugriff (PDF)

Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaign

Journal of the European Academy of Dermatology and Venereology, 2019-03, Vol.33 (S2), p.76-88

2019

Volltextzugriff (PDF)

The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection

Oncogene, 2006-05, Vol.25 (22), p.3186-3195

2006

Volltextzugriff (PDF)

Proteasome inhibitor therapy for antibody-mediated rejection

Pediatric transplantation, 2011-09, Vol.15 (6), p.548-556

2011

Volltextzugriff (PDF)

PO4-7: Functional selectivity of the insulin-like growth factor type 1 receptor (IGF-1R) signaling: therapeutic implications for cancer treatment

Growth hormone & IGF research, 2014-10, Vol.24, p.S51-S51

2014

Volltextzugriff (PDF)

PO3-12: Balancing the IGF-1R-Mdm2-p53 axis as novel therapeutic strategy in skin melanoma

Growth hormone & IGF research, 2014-10, Vol.24, p.S33-S33

2014

Volltextzugriff (PDF)

1 – 25 von 339

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(322)
Mit Volltextzugriff
(286)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Retraction Note: Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor

Prospective Iterative Trial of Proteasome Inhibitor‐Based Desensitization

Correction: Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma

Correction: Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and β-arrestin1

Role of insulin-like growth factor I receptor signalling in cancer

Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor

β-arrestin1 is involved in the Ras-induced malignant transformation

2035P - β-arrestin1 is involved in the Ras-induced malignant transformation

Randomized Controlled Pilot Study of B Cell–Targeted Induction Therapy in HLA Sensitized Kidney Transplant Recipients

Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma

Functional antagonism of β-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes

Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma

Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real‐world setting

Chapter Seven - When Phosphorylation Encounters Ubiquitination: A Balanced Perspective on IGF-1R Signaling

Corrigendum: Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real‐world setting

Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and β-arrestin1

Prevalence and determinants of sunbed use in thirty European countries: data from the Euromelanoma skin cancer prevention campaign

Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation

Correlation between Solid Phase Assays and Positive CDC Crossmatches in a Surrogate Transplant Model

RETRACTED ARTICLE:Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor

Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaign

The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection

Proteasome inhibitor therapy for antibody-mediated rejection

PO4-7: Functional selectivity of the insulin-like growth factor type 1 receptor (IGF-1R) signaling: therapeutic implications for cancer treatment

PO3-12: Balancing the IGF-1R-Mdm2-p53 axis as novel therapeutic strategy in skin melanoma

Suchergebnisse filtern